Neue Suche | Kongressdetail
Druckansicht
 
 

World CDx: Market Access for Precision Medicine Summit 2017

evvnt Platform / evvnt
Kongressthemen
RandD pipelines are brimming with targeted therapeutic assets and as testified by the recent PMC study, over 25% of drugs approved last year fall into the precision medicine category. Current focus shifts to the reimbursement and commercial strategy to get ROI and bring these ground-breaking medicines to those in need. It's time for discussion and collaboration between regulatory, reimbursement and market access specialists to ensure drug and diagnostic products reach the right patient
Kongressorganizer (PCO)
HansonWade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/116672-1

Speakers: Janaki Veeraraghavan from FDA, Satish Valluri from Pfizer, Boxiong Tang from Teva Pharmaceuticals, Tehseen Salimi from Trevena, Rafael Alfonso from GSK
 

Anfragen und Anmeldung:

https://go.evvnt.com/116672-2
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Early Bird: USD 1999 , Standard: USD 2699
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

FFG - 7. EU-RahmenprogrammOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.newTreeÄrztekammer für WienSwiss Tropical and Public Health InstituteEuropean Public Health Association (EUPHA)

Facebook